Wearable Cardioverter Defibrillators Market Size

  • Report ID: 874
  • Published Date: Nov 17, 2023
  • Report Format: PDF, PPT

Wearable Cardioverter Defibrillators Market Size

Wearable Cardioverter Defibrillators Market size is poised to reach USD 24 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of wearable cardioverter defibrillators was USD 14 Billion. The reason behind the growth is due to the rising incidence of cardiovascular diseases across the globe. Cardiovascular disease deaths have increased by more than 55% worldwide in the past 30 years.

Diabetes-related high blood sugar levels can harm the nerves that control the heart and blood vessels, resulting in a variety of cardiovascular diseases such as coronary artery disease, which affects the electrical conduction system in the heart, causing ventricular arrhythmias and atrial fibrillation. This increases the demand for common cardiac disease and rhythm monitoring, which is likely to boost market growth. 

The growing technological advancement in cardiology are believed to fuel the market growth. For instance, artificial intelligence (AI) components are already being utilized in radiology and cardiology's backends including wearable cardiac monitoring devices and point-of-care (POC) triage apps that are being utilized with wearables or smartphone-based apps that record ECG to automatically detect arrhythmias and notify patients.


Wearable-Cardioverter-Defibrillators-Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 874
  • Published Date: Nov 17, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising incidence of heart attacks across the globe and the growing technological advancement in cardiology are the major factors driving the growth of the market.

The market size of Wearable Cardioverter Defibrillators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024 – 2036.

The major players in the market are ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company., and others.

The peripartum cardiomyopathy segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying